VENENTOCLAX
Clinical trials for VENENTOCLAX explained in plain language.
Never miss a new study
Get alerted when new VENENTOCLAX trials appear
Sign up with your email to follow new studies for VENENTOCLAX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep High-Risk leukemia in remission before transplant
Disease control Recruiting nowThis study tests whether a combination of venetoclax and azacitidine works better than standard chemotherapy to keep high-risk acute myeloid leukemia (AML) from coming back before a stem cell transplant. About 216 adults who have already achieved remission after initial treatment…
Matched conditions: VENENTOCLAX
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to boost stem cell transplant success in older blood cancer patients
Disease control Recruiting nowThis phase 3 trial tests whether adding the targeted drug venetoclax to standard chemotherapy (fludarabine and melphalan) before a donor stem cell transplant can improve outcomes for patients over 50 with acute myeloid leukemia or myelodysplastic syndrome. The study will compare …
Matched conditions: VENENTOCLAX
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC